Cargando…
Correction: Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
Autores principales: | Stankowska, Dorota L., Nam, Mi-Hyun, Nahomi, Rooban B., Chaphalkar, Renuka M., Nandi, Sandip K., Fudala, Rafal, Krishnamoorthy, Raghu R., Nagaraj, Ram H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668458/ https://www.ncbi.nlm.nih.gov/pubmed/31372242 http://dx.doi.org/10.1038/s41420-019-0201-7 |
Ejemplares similares
-
Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
por: Stankowska, Dorota L., et al.
Publicado: (2019) -
Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
por: Nam, Mi-Hyun, et al.
Publicado: (2022) -
Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
por: Chaphalkar, Renuka M., et al.
Publicado: (2020) -
Kynurenic Acid Protects Against Ischemia/Reperfusion-Induced Retinal Ganglion Cell Death in Mice
por: Nahomi, Rooban B., et al.
Publicado: (2020) -
Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
por: Phatak, Nitasha R., et al.
Publicado: (2016)